Class action, page-216

Yes I agree the ADAPT s. potential has not be fully exploited . Just hang in there I feel this can turn around very quickly if they can cut a deal on the TAVR . I feel AHZ would be better to partner with a major on both the ADAPT and TAVR projects . The fact that the ADAPT has been approved in EU and US would be very enticing to some of the majors They would already have a much bigger and better marketing network already on the ground thus saving AHZ a large portion of their expenses . A deal like this could secure AHZ a very substantial upfront payment , also surgeons would be more likely to use the ADAPT product when supplied from a major manufacturer